Atlas Wealth’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-159,770
Closed -$2.83M 100
2024
Q2
$2.83M Buy
+159,770
New +$2.72M 0.33% 63
2023
Q4
Sell
-235,851
Closed -$3.49M 95
2023
Q3
$3.49M Sell
235,851
-7,405
-3% -$114K 0.65% 38
2023
Q2
$3.87M Sell
243,256
-558
-0.2% -$8.63K 0.71% 38
2023
Q1
$3.81M Buy
243,814
+4,735
+2% +$69.1K 0.75% 36
2022
Q4
$3.21M Buy
+239,079
New +$3.27M 0.87% 29

Other funds holding ECAT

Atlas Wealth's ECAT Position: Q3 2024 in Review

Atlas Wealth sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2024, closing a stake of 159,770 shares — an estimated $2.83M sold.

Atlas Wealth first reported a position in ECAT in Q4 2022 and held it in 5 quarters. The position peaked at $3.87M in Q2 2023. 65 funds tracked by Wall St. Rank hold ECAT as of Q3 2024.

  • Atlas Wealth reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Atlas Wealth sold 159,770 BlackRock ESG Capital Allocation Term Trust shares in Q3 2024, an estimated $2.83M.
  • Atlas Wealth first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and held it in 5 quarters.
  • Atlas Wealth's BlackRock ESG Capital Allocation Term Trust position peaked at $3.87M in Q2 2023.
  • 65 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2024.

Based on Atlas Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.